1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ADGRL1 CTRPv2 pan-cancer AAC 0.2 2e-08
mRNA C19orf45 CTRPv2 pan-cancer AAC 0.19 2e-08
mRNA SBDS CTRPv2 pan-cancer AAC -0.2 2e-08
mRNA CPSF6 CTRPv2 pan-cancer AAC 0.21 2e-08
mRNA ZNF428 CTRPv2 pan-cancer AAC 0.19 2e-08
mRNA NUCKS1 CTRPv2 pan-cancer AAC 0.19 2e-08
mRNA WDR82 CTRPv2 pan-cancer AAC 0.2 3e-08
mRNA SRP9 CTRPv2 pan-cancer AAC 0.18 3e-08
mRNA USP42 CTRPv2 pan-cancer AAC 0.18 3e-08
mRNA SMAD4 CTRPv2 pan-cancer AAC 0.19 3e-08
Download CSV